Prevalence of non-hodgkin lymphoma patients at high-risk of failure after car t-cell therapy eligible for bridging radiation therapy

HIGHLIGHTS

• What: The authors aim to determine the prevalence of patients with NHL meeting high-risk criteria who have disease that could be encompassed in a standard radiation plan prior to receiving CD19 CART. Statistical analysis was performed using the R language . volume was not calculated for the purposes of this study.
• Who: Adnan Danish from the Raffaele University, Italy have published the Article: Prevalence of non-Hodgkin lymphoma patients at high-risk of failure after CAR T-cell therapy eligible for bridging radiation therapy, in the Journal: (JOURNAL)
• How: The study was conducted . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.